Impact of the COVID-19 Pandemic on the Surgical Activity of Bellvitge University Hospital

Sponsor
Hospital Universitari de Bellvitge (Other)
Overall Status
Completed
CT.gov ID
NCT04780594
Collaborator
(none)
2,530
1
9.9
256.7

Study Details

Study Description

Brief Summary

COVID-19 has been a challenge for hospitals; there was an obvious need to reconvert many spaces in specific areas to attend this pathology, without forgetting the attention to other pathologies and surgery. The objective of the investigators is to evaluate the impact of this pandemic in the patients who underwent surgery in Bellvitge University Hospital, analyzing 2 periods of time: the months before the COVID-19 peak and the COVID-19 peak months.

Condition or Disease Intervention/Treatment Phase
  • Procedure: The study evaluates all surgical patients operated, both elective scheduled and emergent cases

Detailed Description

A total of 2.530 procedures have been evaluated in this retrospective observational study. Two groups have been generated (pre-pandemic period and pandemic period), classified into scheduled and emergency surgery. The investigators determined age, type of surgery and specialty, hospital stay, destination at discharge including mortality and severity according to Diagnostic Related to Group (DRG) scale. The investigators have also determined the number of confirmed COVID-19 infections in patients who underwent surgery during these 2 periods and evaluated if the infection was due to a nosocomial infection (confirmation of the COVID-19 during the hospitalization period). Comparisons were made between subgroups: scheduled surgery performed during the 2 periods and emergency surgery performed during the 2 periods.

Study Design

Study Type:
Observational
Actual Enrollment :
2530 participants
Observational Model:
Case-Crossover
Time Perspective:
Retrospective
Official Title:
Impact of the SARS-CoV-2 (COVID-19) Pandemic on the Morbidity and Mortality of Patients Undergoing Surgery at Bellvitge University Hospital
Actual Study Start Date :
Feb 13, 2020
Actual Primary Completion Date :
May 15, 2020
Actual Study Completion Date :
Dec 9, 2020

Arms and Interventions

Arm Intervention/Treatment
Pre-pandemic COVID-19 group (PreCOVID)

All patients who underwent surgery from 13th January until 29th February 2020, which are considered free of COVID-19 patients, therefore pre-pandemic period.

Procedure: The study evaluates all surgical patients operated, both elective scheduled and emergent cases
Administrative database was automatically collected. That included demographic, clinical antecedents, surgical team and surgical procedure, primary and secondary diagnoses and principal and secondary surgical procedures. A case-mix grouping system administrative automatic recorded based on the ICD-10-AM International Classification of Diseases. According to the Diagnoses-related Groups (DRG's). the Severity of Illness Index assigns to each patient an overall severity score (from 1 to 4) and mortality risk score (from 1 to 4)

Pandemic COVID-19 group (COVID)

All patients who underwent surgery from 11th March 2020 until 15th May 2020, which were done during the first wave of the pandemic crisis.

Procedure: The study evaluates all surgical patients operated, both elective scheduled and emergent cases
Administrative database was automatically collected. That included demographic, clinical antecedents, surgical team and surgical procedure, primary and secondary diagnoses and principal and secondary surgical procedures. A case-mix grouping system administrative automatic recorded based on the ICD-10-AM International Classification of Diseases. According to the Diagnoses-related Groups (DRG's). the Severity of Illness Index assigns to each patient an overall severity score (from 1 to 4) and mortality risk score (from 1 to 4)

Outcome Measures

Primary Outcome Measures

  1. Register the post-surgical complications [PreCOVID group from 13th January 2020 to 29th February 2020 and COVID group from 11th March 2020 to 15th May 2020.]

    Register and Compare the Rate of Surgical Reintervention between both periods.

Secondary Outcome Measures

  1. Register the rate of surgical reintervention [PreCOVID group from 13th January 2020 to 29th February 2020 and COVID group from 11th March 2020 to 15th May 2020.]

    Register and compare the Rate of reintervention between both periods.

  2. Register the ICU admission [PreCOVID group from 13th January 2020 to 29th February 2020 and COVID group from 11th March 2020 to 15th May 2020.]

    register and compare the ICU admission between both periods.

  3. Register the Hospital stay [PreCOVID group from 13th January 2020 to 29th February 2020 and COVID group from 11th March 2020 to 15th May 2020.]

    register and compare the ICU admission between both periods.

  4. Register the Mortality [PreCOVID group from 13th January 2020 to 29th February 2020 and COVID group from 11th March 2020 to 15th May 2020.]

    register and compare the Mortality between both periods.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • All surgical patients operated, both elective scheduled and emergent cases
Exclusion Criteria:
  • Minor-intermediate surgery that involves discharge from the hospital on the same day of the surgery from the Pre-pandemic period.

  • Procedures related to medical treatment or complications of COVID-19 patients, such as chest tubes, extracorporeal oxygenation or tracheostomy.

  • Those scheduled elective surgery patients in the Covid period that resulted RT-PCR positive, surgery was posponed, were not considered eligible for the analysis.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Marta Caballero Hospitalet de Llobregat Barcelona Spain 08907

Sponsors and Collaborators

  • Hospital Universitari de Bellvitge

Investigators

  • Principal Investigator: Maria Jose MJ Colomina, PhD, Head of the Department

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Marta Caballero Milan, Medical Staff in Anaesthesiology and Reanimation, Hospital Universitari de Bellvitge
ClinicalTrials.gov Identifier:
NCT04780594
Other Study ID Numbers:
  • COVID19 surgical impact
First Posted:
Mar 3, 2021
Last Update Posted:
Mar 3, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Marta Caballero Milan, Medical Staff in Anaesthesiology and Reanimation, Hospital Universitari de Bellvitge
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 3, 2021